tiprankstipranks
Trending News
More News >
Cara Therapeutics (CARA)
NASDAQ:CARA

Cara Therapeutics (CARA) Revenue

Compare
2,286 Followers

Cara Therapeutics Revenue

Cara Therapeutics had a revenue of 0.00 in the quarter ending Dec 31, 2023, with -100.00%. This bring the company's revenue in the last twelve months to 17.96M, Increased -15.36%. In the fiscal year ending Dec 31, 2023, Cara Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
17.96M
Revenue Growth
-65.96%
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
10
Market Cap
$22.41M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
0.00
Dec 31, 2022
0.00-23.03M-100.00%
Dec 31, 2021
23.03M-112.05M-82.95%
Dec 31, 2020
135.08M115.20M+579.28%
Dec 31, 2019
19.89M6.42M+47.64%
Dec 31, 2018
13.47M12.56M+1,378.49%
Dec 31, 2017
911.00K825.00K+959.30%
Dec 31, 2016
86.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis